Site Name: USA - Pennsylvania - Upper Providence, UK - County Durham - Barnard Castle, UK - Hertfordshire - Stevenage, UK - Hertfordshire - Ware, UK - London - Brentford, USA - North Carolina - Research Triangle Park, USA - Pennsylvania - King of Prussia Posted Date: May 12 2022 Are you interested in a highly visible leadership role, supporting delivery of our innovative portfolio of small molecule & oligonucleotide assets? This opportunity will allow you to influence the development strategy, lead delivery of the CMC, clinical supply and regulatory targets and lead the high performing matrix team; thereby shaping the medicine and supporting our ambitions for patient treatments. If so, this Senior Director, Medicine Process Delivery Leader, Small Molecules role is an exciting move to explore. The role: This is a key leadership position in GSK, leading across R&D and Pharma Supply Chain, defining and delivering the global CMC development and industrialisation strategy and plan for a new medicine. The successful candidate will join the Medicine & Process Delivery team, taking on a significant asset in our small molecule & oligonucleotide pipeline. Key responsibilities: Leads CMC development and industrialisation of a medicine: Leads the definition and implementation of the global CMC development and industrialisation strategy and plan for a medicine, aligning with the global medicine development strategy and plan, the needs of the patient, the commercial intent for the medicine, the overall business context and the regulatory, compliance and manufacturing network requirements Provides options for CMC delivery to align with the project objectives, with recommendations based on sound judgement on both short- and long-term implications (risks, costs, resources and time) for the global lifecycle of the medicine Anticipates, and appropriately plans for, future CMC requirements and risks to enable the full global clinical and commercial lifecycle of the medicine Leads the CMC matrix team: Leads the cross-functional multi-disciplinary CMC matrix team (~10 core team members from R&D and Pharma Supply Chain encompassing technical, quality, regulatory, supply chain and manufacturing; ~50 extended team members) to develop and execute the CMC project plans to accomplish the project aligned objectives to time, budget and resource forecasts Owns the performance of the CMC matrix team: partners with line managers to appropriately resource the project with the right expertise, and to develop and support the core and extended team members to drive performance and deliver the project Scope of activities covered by CMC matrix team: Development of the physical product, process, device and analytical methods Establishment of the clinical and commercial supply chains, manufacturing processes and control strategies Supply of clinical and initial commercial material Clinical and commercial pack and label Transfer of the process and methods from R&D to first commercial manufacture/testing site Definition and delivery of the CMC regulatory strategy, submissions and responses to regulatory questions Launch readiness Voice of CMC for the project: Provides the voice of the physical product and supply chain to influence the medicine development and commercialisation strategies and plans, ensuring appropriately gated commitment to, and investment in, CMC activities Provides the voice of the project to the CMC matrix team to align the CMC plans with the project intent and corporate goals, and to the CMC and commercial manufacturing functional lines to ensure they have the capability and capacity to deliver Aligns senior leaders across R&D and PSC (via governance bodies) on the strategic CMC objectives, plans and risk mitigation activities for the project and the investments and resources required to deliver these Integrates across R&D and PSC to deliver the project via the CMC Matrix Team and close communication with senior stakeholders Provides CMC input to due diligence reviews of new asset business development proposals, positioning the CMC opportunities and risks in the context of the proposed medicine and business strategy Skills and competencies This role requires the knowledge, gravitas, courage and credibility to lead a high performing multi-disciplinary matrix team of CMC and supply chain experts to develop and deliver the manufacturing process, supply chain, physical medicinal product and regulatory submissions to enable clinical trials, regulatory approval and a secure commercial supply of a medicine. An exceptional matrix leader: Sets direction, empowers others to take ownership of their activities, monitors progress, knows when and how to intervene to avoid or manage risks and issues, helps remove barriers, holds team members accountable for their delivery and performance on behalf of the team and the enterprise A curious scientific intellect, a critical thinker with sound judgement Strong decision-making skills An agile and willing learner Creative problem solver: able to analyse and interpret complex situations to provide innovative solutions and clear strategic direction to others An active and empathetic listener who is aware of own limitations in knowledge, expertise or experience Able to influence at all levels in the business and across multiple disciplines Masterful manager of conflict Collaborative, cooperative, inclusive and transparent, builds and cultivates high performing teams and partnerships Excellent communicator both verbal and written A highly credible CMC or supply chain expert: Strong technical knowledge of process, product and analytical development Strong CMC regulatory and compliance knowledge Strong knowledge of commercial supply chain implementation Awareness of compliance and regulatory requirements for clinical and commercial manufacturing Advanced knowledge of the drug development process Awareness of CMC as part of the whole, with a broad knowledge of the E2E non-clinical, clinical, regulatory and commercial aspects of developing a medicine Analyses, interprets and critically evaluates data and information to determine and justify decisions or recommendations Business savvy: Connected to the broader business with a wide internal and external network Able to balance scientific, technical and manufacturing risks against the overall business impact Understands the business financial context within which decisions are made Experience Significant experience working in a CMC and supply chain organisation (e.g. process, product or analytical development, manufacturing, supply chain, quality, CMC regulatory) Recognised internally, and preferably externally, as a thought leader or subject matter expert in a relevant CMC discipline Experience in CMC medicine development, particularly late stage and preferably through to successful product approval and launch Successful developer of people as a mentor, coach, matrix and line leader Successfully led large, complex, cross-functional teams, with high level of accountability, preferably in an international context and preferably with external partners Significant experience working directly with senior executives Why you? Basic qualifications: Bachelor of Science with director level CMC experience in the development and manufacture of relevant pharmaceuticals Experience of the relevant CMC and supply chain aspects of developing, manufacturing and industrializing small molecules or oligonucleotides along with of the pharmaceutical industry, relevant regulations and requirements Experience creating and defending CMC development strategy, plan and data package for an asset Project leadership experience, specifically leadership of multi-disciplinary teams and preferably in a relevant pharmaceutical product development environment with global teams Experience in a senior director role with both internal and external groups Preferred qualifications: PhD/EngD with extensive CMC experience in the development or manufacture of relevant pharmaceuticals Learning agility and desire to learn new things outside of one's comfort zone; willingness to take on diverse and agnostic assignments in product development Why GSK? At GSK, we have already delivered unprecedented change over the past four years, improving R&D, becoming a leader in Consumer Health, strengthening our leadership, and transforming our commercial execution. Now, we're making the biggest changes we've made to our business in over 20 years. We're on track to separate and create two new companies in 2022: New GSK with a leading portfolio of vaccines and specialty medicines as well as R&D based on immune system and genetics science; and a new world-leading consumer healthcare company of loved and trusted brands. With new ambition comes new purpose. For New GSK, this is to unite science, talent and technology to get ahead of disease together - all with the clear ambition of delivering human health impact; stronger and more sustainable shareholder returns; and as a new GSK where outstanding people thrive. Getting ahead means preventing disease as well as treating it. How we do all this is through our people and our culture. A culture that is ambitious for patients - so we deliver what matters better and faster; accountable for impact - with clear ownership of goals and support to succeed; and where we do the right thing. So, if you're ready to improve the lives of billions, join us at this exciting moment in our journey. Join our challenge to get Ahead Together. *LIGSK If you require an accommodation or other assistance to apply for a job at GSK, please contact the GSK Service Centre at 1-877-694-7547 (US Toll Free) or +1 801 567 5155 (outside US). GSK is an Equal Opportunity Employer and, in the US, we adhere to Affirmative Action principles. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, national origin, religion, sex, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class. At GSK, the health and safety of our employees are of paramount importance. As a science-led healthcare company on a mission to get ahead of disease together, we believe that supporting vaccination against COVID-19 is the single best thing we can do in the US to ensure the health and safety of our employees, complementary workers, workplaces, customers, consumers, communities, and the patients we serve. GSK has made the decision to require all US employees to be fully vaccinated against COVID-19, where allowed by state or local law and where vaccine supply is readily available. The only exceptions to this requirement are employees who are approved for an accommodation for religious, medical or disability-related reasons. Important notice to Employment businesses/ Agencies GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site. Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK's compliance to all federal and state US Transparency requirements. For more information, please visit GSK's Transparency Reporting For the Record site.